Evidence map›Paper›PMID 27495040›Full record

ArticleMedicine2016

Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning.

Hossein Hassanian-Moghaddam, Nasim Zamani

Abstract readComparative Study
In one paragraph

Article in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Successfully managed aluminum phosphide poisoning: A case report.Annals of medicine and surgery (2012) · 2021
    Article
  11. Human Zinc Phosphide Exposure in Lebanon: A Case Report and Review of the Literature.Clinical practice and cases in emergency medicine · 2021
    Article
  12. Survival after Aluminum Phosphide Poisoning in Pregnancy.Case reports in emergency medicine · 2020
    Article
  13. Observational
  14. Re: Thoughts on the Current Management of Acute Aluminum Phosphide Toxicity and Proposals for Therapy: An Evidence-based Review.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2017
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hossein Hassanian-MoghaddamToxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences Excellence Center of Clinical Toxicology, Iranian Ministry of Health, Tehran, Iran.
Nasim Zamani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferent protocols have been suggested to treat aluminum phosphide (ALP) poisoning. We aimed to evaluate the possible therapeutic effect of hyperinsulinemia/euglycemia (HIE) in treatment of ALP poisoning.

methodsIn a prospective interventional study, a total of 88 ALP-poisoned patients were included and assigned into HIE group undergoing glucose/insulin/potassium (GIK) protocol and a control group that was managed by routine conventional treatments. The 2 groups were then compared regarding the signs and symptoms of toxicity and their progression, development of complications, and final outcome to detect the possible effect of GIK protocol on the patients' course of toxicity and outcome.

resultsThe 2 groups were similar in terms of demographic characteristics and on-arrival vital signs and lab tests. Using GIK protocol resulted in significantly longer hospital stays (24 vs 60 hours; P < 0.001) and better outcomes (72.7% vs 50% mortality; P = 0.03). Regression analysis showed that GIK duration was an independent variable that could prognosticate mortality (odds ratio [95% confidence interval] = 1.045 [1.004,1.087]). The risk of mortality decreased by 4.5% each hour after initiation of GIK.

conclusionGIK protocol improves the outcome of ALP poisoning and increases the length of hospital stay.

Indexed as

AdultAluminum CompoundsBlood GlucoseCohort StudiesConfidence IntervalsFemaleFollow-Up StudiesGlucoseHumansHyperinsulinismInsulinMaleOdds RatioPhosphinesPoisoningProspective StudiesAluminum Compoundsaluminum phosphideBlood GlucoseGlucoseInsulinPhosphines

Identifiers

PMID27495040
PMCPMC4979794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.